Development and Preclinical Evaluation of a Near-Infrared Fluorescence Probe Based on Tailored Hepatitis B Core Particles for Imaging-Guided Surgery in Breast Cancer.

Int J Nanomedicine · 2022 · PMC8957402 · PMID 35345784

Europe PMC DOI

hedged sentence

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

did not reach statistical significanceP <0.01actually significant

This difference did not reach statistical significance, but the 12.25 mg/kg dose was associated with a significantly lower TBR than both the 25 mg/kg and 50 mg/kg doses at 36 h ( P <0.01) ( Figure 2B ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.